Eliminating Hepatitis C in Europe: A report on policy implementation for people who inject drugs
El último informe de la serie 2024 Civil Society Monitoring of Harm Reduction in Europe (Seguimiento de la reducción de daños por parte de la sociedad civil en Europa 2024) analiza la evolución de la atención a la hepatitis C para los consumidores de drogas inyectables, basándose en las observacione...
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Monograph |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
Amsterdam
Correlation - European Harm Reduction Network
2025
|
| Pynciau: | |
| Mynediad Ar-lein: | Enlace web Servidor |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg: Eliminating Hepatitis C in Europe: A report on policy implementation for people who inject drugs
- Evidence for the effectiveness of interventions to prevent infections: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour among people who inject drugs
- Prevention and control of infectious diseases among people who inject drugs
- Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
- Increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process
- Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada
- Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs